LIGAND PHARMACEUTICALS INC — Director's Dealing 2013

Nov 20, 2013

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: LIGAND PHARMACEUTICALS INC (LGND)
CIK: 0000886163
Period of Report: 2013-11-18

Reporting Person: Sharp John P (VP Finance and CFO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2013-11-18	Common Stock	M	624.0	$9.96	Acquired	24790	Direct
2013-11-18	Common Stock	S	1123.0	$53.0	Disposed	23667	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2013-11-18	Non-Qualified Stock Option (right to buy)	$9.96	M	624.0	Disposed	2020-02-15	Common Stock (624)	Direct

Footnotes

F1: Grant to reporting person of options, exercisable over a 4-year period measured from the date of grant, 12-1/2% after six months, then 1/48th of the Option Shares per month thereafter. The date of grant is 02/15/10.